D. A. Cooper
- Virology top 1%
- HIV Research and Treatment 10
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment 5
- HIV/AIDS Research and Interventions 2
- Parvovirus B19 Infection Studies 2
- Hepatology top 5%
- Epidemiology top 5%
- Herpesvirus Infections and Treatments 4
- Emergency Medicine top 5%
- HIV-related health complications and treatments 2
-
- T-cell and Retrovirus Studies 3
-
- Viral-associated cancers and disorders 2
D. A. Cooper
13 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 77
- Virology 682
- Infectious Diseases 773
- Hepatology 225
- Epidemiology 666
- Emergency Medicine 115
Countries citing papers authored by D. A. Cooper
This map shows the geographic impact of D. A. Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. A. Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. A. Cooper more than expected).
Fields of papers citing papers by D. A. Cooper
This network shows the impact of papers produced by D. A. Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. A. Cooper. The network helps show where D. A. Cooper may publish in the future.
Co-authorship network
The 25 scholars most cited alongside D. A. Cooper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Metabolic syndrome in HIV-infected patients using IDF and ATPIII criteria: prevalence, discordance and clinical utility | 2006 | 2 |
| 2 | 2005 | 48 | |
| 3 | 1997 | 23 | |
| 4 | 1995 | 1 | |
| 5 | Current status of clinical trials in HIV disease in Australia. | 1993 | 0 |
| 6 | 1993 | 56 | |
| 7 | Update on reverse transcriptase inhibitors in HIV disease. | 1993 | 1 |
| 8 | Prophylaxis of opportunistic infections in patients with HIV infection. | 1993 | 7 |
| 9 | HIV and malignancy. | 1993 | 2 |
| 10 | 1991 | 202 | |
| 11 | 1990 | 91 | |
| 12 | 1988 | 82 | |
| 13 | 1986 | 6 | |
| 14 | 1985 | 469 | |
| 15 | 1985 | 365 |
About D. A. Cooper
D. A. Cooper is a scholar working on Virology, Infectious Diseases, Emergency Medicine, Epidemiology and Immunology, having authored 15 papers that have together received 1.4k indexed citations. Recurring topics across this work include HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (5 papers), Herpesvirus Infections and Treatments (4 papers), T-cell and Retrovirus Studies (3 papers), HIV/AIDS Research and Interventions (2 papers), Viral-associated cancers and disorders (2 papers), Parvovirus B19 Infection Studies (2 papers) and HIV-related health complications and treatments (2 papers). The work is most often cited by research in Virology (682 citations), Infectious Diseases (773 citations), Hepatology (225 citations), Epidemiology (666 citations) and Emergency Medicine (115 citations). D. A. Cooper has collaborated with scholars based in Australia, Netherlands and Switzerland. Frequent co-authors include Julian Gold, Basil Donovan, Neil Bodsworth, Ronald Penny, Robert Finlayson, B. Tindall, Sally Land, Chris Birch, I. D. Gust and Richard Doherty. Their work appears in journals such as The Journal of Infectious Diseases, Sexually Transmitted Infections, The Lancet, Clinical Infectious Diseases and Queensland's institutional digital repository (The University of Queensland).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.